Intravenous (IV) Busulfan (Bu) Administered Twice Daily During Conditioning Prior to Allogeneic Stem Cell Transplant (AlloSCT) in Pediatric Recipients Has Significantly Different Half-Life of Elimination and Clearance in Recipients >4 Years and Those ≤ 4 Years
J.B. LeGall; M. Milone; I. Waxman; L. Shaw; L. Harrison; D. Duffy; C. van de Ven; O. Militano; M. Geyer; E. Morris; L. Baxter Lowe; M.S. Cairo
- 作者J.B. LeGall; M. Milone; I. Waxman; L. Shaw; L. Harrison; D. Duffy; C. van de Ven; O. Militano; M. Geyer; E. Morris; L. Baxter Lowe; M.S. Cairo
- 卷第18卷
- 印刷ISSN1083-8791
- 文件大小70.27KB
- 发表时间2012
- DOI10.1016/j.bbmt.2011.12.256